Advocacy Webpage Graphics Narrow Teach It 

Addiction is a complex medical disease that has become a public health emergency throughout the US. ASAM advocates for policies that grow the addiction medicine workforce by integrating addiction medicine into medical school and residency curricula, supporting training programs, and incentivizing clinicians to work in programs and practices that specialize in the treatment of substance use disorder.




What is Addiction?

Addiction is a primary, chronic disease of brain reward, motivation, memory and related circuitry.

Click here to learn more




 
FOAM-header
 



Featured Public Policy Statements

_82007387_thinkstockphotos-515008423

E-Cigarettes

Learn more about ASAM's position on E-Cigarettes as a potential harm reduction strategy and for smoking cessation.

The Role of Recovery in Addiction Care

In ASAM’s definition, recovery from addiction is an active process of continual growth that addresses the biological, psychological, social and spiritual disturbances inherent in addiction.

Substance Use, Misuse, and Use Disorders During and Following Pregnancy, with an Emphasis on Opioids

Learn more about ASAM's policy recommendations on substance use, misuse, and SUDs during and following pregnancy.

Naloxone_2_(cropped)2

Use of Naloxone for the Prevention of Opioid Overdose Deaths

See ASAM's policy recommendations on Naloxone prescribing, training, and use.  







Strengthening the Substance Use Disorder Workforce Graphic




"When something is stigmatized nobody wants to bring it up,
so therefore people who need the help are less willing to come forward."

Corey Waller, MD, MS, FACEP, DFASAM
Member of ASAM's Legislative Advocacy Committee




Resources

11_PayForQuality - Copy


Learn more about the three medications currently approved by the FDA to treat opioid use disorder.

Updating map


How is the opioid overdose epidemic affecting your state?

cdc

Check out this CDC report and learn more about effective strategies to prevent opioid overdose in your community.

training

Learn more about the growing problem of controlled substance diversion from presentations made at the DEA Practitioner Diversion Awareness Conference

 
ecigarette2


Learn more about what the US Surgeon General has to say about e-cigarettes

 





ACCME 

Learn more about how ASAM is working to educate the next generation of addiction medicine professionals.





Related News

newspapers-3488857_1920B

ASAM Praises Funding for Critical SUD Workforce Programs in FY 2020 House Labor-HHS Appropriations Bill

by | May 09, 2019

House Bill Would Fully Fund Two New Programs to Train and Expand Addiction Treatment Workforce in Underserved Communities


Download Release

Rockville, MD – The American Society of Addiction Medicine (ASAM) today praised the House Appropriations Committee for including full funding for two new critical substance use disorder (SUD) workforce programs in its FY 2020 Labor, Health and Human Services (HHS), Education, and Related Agencies appropriations bill.

The bill includes $25 million for the Loan Repayment Program for Substance Use Disorder (SUD) Treatment Workforce, which was authorized in last year’s SUPPORT for Patients and Communities Act. The program will provide student loan relief to addiction treatment professionals who commit to working in designated Mental Health Professional Shortage Areas or in counties where the average overdose death rate is higher than the national average. Last month, Representatives Katherine Clark (D-MA) and Hal Rogers (R-KY) led a bipartisan House letter in support of the program.

The package also includes $10 million for grants to institutions that provide training opportunities for medical residents and fellows in psychiatry and addiction medicine, as well as nurse practitioners, physician assistants and others who are willing to provide SUD treatment in underserved communities. This program was authorized in the 21st Century Cures Act in 2016. Representatives Annie Kuster (D-NH), Antonio Delgado (D-NY) and John Katko (R-NY) led a bipartisan House letter in support of the program last month.

“We applaud Labor-HHS Subcommittee Chairwoman Rosa DeLauro and other Committee members for recognizing the need to invest in the addiction treatment workforce and urge Senate leaders to do the same,” said Paul H. Earley, MD, DFASAM, president of ASAM. “This critical funding – which will help train and deploy qualified treatment professionals to communities hardest hit by the drug overdose crisis – will be a significant step toward closing a substantial SUD treatment gap.”

Both programs will increase the ranks of qualified, well-trained addiction treatment professionals in underserved communities at a time of great need. According to the latest estimates, nearly 21 million Americans needed treatment for SUD in 2017, but only 4 million received any form of SUD treatment or ancillary services. There are currently too few clinicians with the requisite knowledge and training to prevent, diagnose, and treat the disease of addiction. Furthermore, addiction training is not commonly included in American medical education. Since addiction medicine was only formally recognized as a medical subspecialty in 2016, the field is still catching up with other specialties in terms of available teaching and training opportunities.

Strategic investments are needed now to attract more students and professionals to the addiction medicine subspecialty and deploy qualified treatment professionals to high-need areas.

###

 About ASAM
The American Society of Addiction Medicine (ASAM), founded in 1954, is a professional medical society representing over 6,000 physicians, clinicians and associated professionals in the field of addiction medicine. ASAM is dedicated to increasing access and improving the quality of addiction treatment, educating physicians and the public, supporting research and prevention, and promoting the appropriate role of physicians in the care of patients with addiction. For more information, visit www.ASAM.org.